Healthy Skepticism Library item: 5148

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Grossman D, Ellertson C, Abuabara K, Blanchard K, Rivas FT.
Barriers to contraceptive use in product labeling and practice guidelines.
Am J Public Health 2006 May 01; 96:(5):791-9
http://www.ajph.org/cgi/content/full/96/5/791

Abstract:

Many contraceptives are encumbered with potentially unnecessary restrictions on their use. Indeed, fear of side effects, fostered by alarmist labeling, is a leading reason that women do not use contraceptives.In the United States, hormonal methods currently require a prescription, although research suggests that women can adequately screen themselves for contraindications, manage side effects, and determine an appropriate initiation date, leaving little need for routine direct physician involvement. Sizing, spermicidal use, and length-of-wear limits burden users of cervical barriers and may be unnecessary. Despite recent changes in the labeling of intrauterine devices, clinicians commonly restrict use of this method and in some countries may limit the types of providers authorized to insert them.Although in some cases additional research is necessary, existing data indicate that evidence-based demedicalization of contraceptive provision could reduce costs and improve access.

Keywords:
Contraception Behavior* Contraceptive Devices, Female/utilization* Contraceptives, Oral/administration & dosage* Drug Labeling/standards* Drug Utilization Female Health Services Accessibility/standards Humans Patient Education Practice Guidelines/standards* Research Support, Non-U.S. Gov't